We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Comes Down on API Repackers for Quality Violations
FDA Comes Down on API Repackers for Quality Violations
The FDA issued warning letters to three active pharmaceutical ingredient repackers, urging them to clearly identify the original manufacturer of the drugs — including opioids — to customers who use them in their finished products.